Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an announcement.
Rhythm Biosciences has entered a strategic co-marketing partnership with the Know Your Lemons Foundation to promote its geneTypeTM Breast Cancer Risk Assessment Test. This collaboration aims to enhance brand awareness and commercialize the test by integrating it into the Know Your Lemons mobile app, reaching a vast audience of women in the US and Australia. The partnership aligns with Breast Cancer Awareness Month, leveraging the global campaign to emphasize early detection and proactive health management, potentially impacting the company’s market position and stakeholder engagement.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian medical diagnostics company focused on delivering simple, affordable blood tests for early cancer detection. Founded in 2017 and headquartered in Melbourne, the company aims to improve patient outcomes by detecting cancers at the earliest stages, thereby reducing the global cancer burden. Rhythm Biosciences collaborates with global partners to commercialize and distribute their diagnostic solutions.
Average Trading Volume: 751,731
Technical Sentiment Signal: Buy
Current Market Cap: A$28.5M
See more data about RHY stock on TipRanks’ Stock Analysis page.